康大伟,于健,巨明飞. 去甲肾上腺素联合磷酸肌酸钠对感染性休克患者早期心功能的影响[J]. 中国急救医学, 2018, 38(4): 319-.
Kang Da-wei, Yu Jian, Ju Ming-fei. The effect of norepinephrine combined with sodium phosphocreatine on the early cardiac function of patients with septic shock. Chinese Journal of Critical Care Medicine, 2018, 38(4): 319-.
[1]Smeding L, Plfitz FB, Groeneveld AB, et al. Structural changes of the heart during severe septic shock or septic shock[J]. Shock, 2012, 37 (5):449-456.
[2]耿丽娟,李素玮,张永利,等.感染性休克心肌损伤发病机制的研究进展[J].中华内科杂志, 2015, 54(1):77-80.
[3]Rhodes A, Evans LE, Alhazzani W. Surviving Sepsis Campaign:International Guidelines for Management of Spsis and Septic Shock:2016[J]. Crit Care Med, 2017, 45(3):486-552.
[4]Hamzaoui O, Georger JF, Monnet X, et al. Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension[J]. Crit Care, 2010, 14(4):R142
[5]Blanco J, Muriel-Bombin A, Sagredo V,et al. Incidence, organ dysfunction and mortalityin severe septic shock: a Spanish multicentre study[J]. Crit Care, 2008, 12(6): R158.
[6]Maack C,O'Rourke B.Excitation-contraction coupling and mitochondrial energetics[J]. Basic Res Cardiol, 2007, 102(5):369-392.
[7]陈琳,陈霞,张胜武.磷酸肌酸钠对感染性休克患者心肌损伤的保护作用[J].全科医学临床与教育, 2016, 14(5):513-516.
[8]马光,洪广亮,赵光举,等. 感染性休克患者血浆B型尿钠肽和肌钙蛋白Ⅰ的变化及意[J].中国中西医结合急救杂志, 2014, 21(2):99-103.
[9]Klouche K, Pommet S, Amigues L, et al. Plasma brain natriuretic peptide and troponin levels in severe septic shock and septic shock: relationships with systolic myocardial dysfunction and intensive care unit mortality[J]. J Intensive Care Med, 2014, 29(4):229-237.
[10]Vanasco V, Cimolai MC, Evelson P, et al. The oxidative stress and the mitochondrial dysfunction caused by endotoxemia are prevented by alpha-lipoic acid[J]. Free Radic, 2008, 42(9):815-823.
[11]Chen H, Gong C, Ma C, et al. Cardioprotective effects of phosphocreatine on myocardial cellultra structure and calcium-sensing receptor expression in the acute period following high level spinal cord injury[J]. Mol Med Rep, 2014, 10(1):560-566.
[12]Zou LL, Li QS, Han GZ, et al. Pharma cokinetics and metabolic disposition of exogenous phosphocreatine in rats[J]. Yao Xue Xue Bao, 2011, 46(1):75-80.
[13]刘梅,石海霞,仲盛年,等.脓毒症患者血清氨基酸末端B型利钠肽前体和心肌酶水平及临床意义[J].中国老年学杂志, 2017, 37(1):177-179.